AxeroVision, Inc.
Research - Carlsbad, California, United States
AxeroVision, Inc. Employees
AxeroVision, Inc. Senior Management
AxeroVision, Inc. Details
AxeroVision is developing novel therapies for the treatment of ophthalmic inflammatory diseases, such as Dry Eye Disease (DED) and Meibomian Gland Dysfunction (MGD). AXR-159 is being developed for the treatment of chronic DED. AXR-270 is being developed for the short-term treatment of DED. Both assets have achieved clinical proof-of-concept.
Website:
http://www.axerovision.com
Employees:
1
HQ:
(850) 512-7826
Location:
Carlsbad, California, United States
Revenue:
AxeroVision, Inc. Technologies
Email Providers
Outlook
Fonts
Typekit
Other
Mobile Friendly